IZALTREO Trademark

Trademark Overview

On Thursday, June 14, 2018, a trademark application was filed for IZALTREO with the United States Patent and Trademark Office. The USPTO has given the IZALTREO trademark a serial number of 88000057. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 17, 2022. This trademark is owned by Glaxo Group Limited. The IZALTREO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
izaltreo

General Information

Serial Number88000057
Word MarkIZALTREO
Filing DateThursday, June 14, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 17, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 16, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 19, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Tuesday, January 18, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 17, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 17, 2021EXTENSION 5 GRANTED
Wednesday, May 12, 2021EXTENSION 5 FILED
Wednesday, May 12, 2021TEAS EXTENSION RECEIVED
Thursday, October 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 20, 2020EXTENSION 4 GRANTED
Tuesday, October 20, 2020EXTENSION 4 FILED
Tuesday, October 20, 2020TEAS EXTENSION RECEIVED
Wednesday, February 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 25, 2020EXTENSION 3 GRANTED
Monday, February 17, 2020EXTENSION 3 FILED
Tuesday, February 25, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 17, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 17, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 17, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 17, 2020TEAS EXTENSION RECEIVED
Wednesday, December 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 9, 2019EXTENSION 2 GRANTED
Monday, December 9, 2019EXTENSION 2 FILED
Monday, December 9, 2019TEAS EXTENSION RECEIVED
Wednesday, June 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2019EXTENSION 1 GRANTED
Monday, June 3, 2019EXTENSION 1 FILED
Monday, June 3, 2019TEAS EXTENSION RECEIVED
Tuesday, December 11, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 16, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 16, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 26, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 12, 2018ASSIGNED TO EXAMINER
Tuesday, June 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 18, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

izaltreo pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological